Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Open in API
Filings indexed 252 across all filing types
Latest filing 2023-05-02 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory filing submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It contains certification by an officer (CFO) confirming the accuracy of the information provided, including market values and trading periods. The document does not contain financial statements, detailed financial analysis, or report content but is primarily a certification and fee calculation form. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing specific forms or financial periods, should be classified as Regulatory Filings (RNS). The document length is moderate but the content is clearly a certification form rather than a full financial report or announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-05-02 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1, which is a management certification related to participation fees for reporting issuers, submitted to the Alberta Securities Commission. It includes officer certification statements, market value calculations, and fee details. The document is primarily a certification and fee calculation form, not a financial report or earnings release. It does not contain comprehensive financial statements or detailed management discussion. It is a regulatory filing submitted to a securities commission, and the main content is a certification by an officer regarding the accuracy of the information. Therefore, it fits best under Regulatory Filings (RNS) as it is a certification and fee form rather than a full report or announcement of results.
2023-05-02 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 95% confidence The document is titled 'Independent Auditor's Report' and contains detailed audit opinions, financial statements including consolidated statements of financial position, loss and comprehensive loss, changes in shareholders' equity, cash flows, and notes to the consolidated financial statements for the years ended December 31, 2022 and 2021. It includes the auditor's opinion on the financial statements, basis for opinion, key audit matters, and responsibilities of management and auditors. The content is comprehensive and contains actual financial data and analysis, not just an announcement or certification. This matches the definition of an Audit Report / Information (AR) filing, which is a standalone audit report including applied accounting principles and audit results, distinct from a full Annual Report (10-K). The document length (15,000 characters) and detailed financial data confirm it is not a brief announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2022
2023-05-02 English
Other.pdf
Regulatory Filings
2023-03-29 English
Material change report - English.pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 51-102F3 Material Change Report filed by Ovation Science Inc. It details a material change event, specifically the entering into a supply and distribution agreement. The document is short (1721 characters) and structured as a regulatory disclosure of a material event rather than a financial report or earnings release. It does not contain financial statements or detailed financial analysis. The form number and content indicate it is a material change report, which is a type of regulatory filing to inform investors of significant corporate events. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-03-29 English
News release - English.pdf
Regulatory Filings
2023-03-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.